Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice
- PMID: 28970251
- DOI: 10.1096/fj.201700600R
Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice
Abstract
Administration of exosomes derived from mesenchymal stromal cells (MSCs) could improve some neurologic conditions by transferring functional biomolecules to recipient cells. Furthermore, exosomes from hypoxic progenitor cells exerted better therapeutic effects in organ injury through specific cargoes. However, there are no related reports about whether exosomes derived from MSCs or hypoxia-preconditioned MSCs (PC-MSCs) could prevent memory deficits in Alzheimer disease (AD). In this study, the exosomes derived from MSCs or PC-MSCs were systemically administered to transgenic APP/PS1 mice. The expression of miR-21 in MSCs was significantly increased after hypoxic treatment. Injection of exosomes from normoxic MSCs could rescue cognition and memory impairment according to results of the Morris water maze test, reduced plaque deposition, and Aβ levels in the brain; could decrease the activation of astrocytes and microglia; could down-regulate proinflammatory cytokines (TNF-α and IL-1β); and could up-regulate anti-inflammatory cytokines (IL-4 and -10) in AD mice, as well as reduce the activation of signal transducer and activator of transcription 3 (STAT3) and NF-κB. Compared to the group administered exosomes from normoxic MSCs, in the group administered exosomes from PC-MSCs, learning and memory capabilities were significantly improved; the plaque deposition and Aβ levels were lower, and expression of growth-associated protein 43, synapsin 1, and IL-10 was increased; and the levels of glial fibrillary acidic protein, ionized calcium-binding adaptor molecule 1, TNF-α, IL-1β, and activation of STAT3 and NF-κB were sharply decreased. More importantly, exosomes from PC-MSCs effectively increased the level of miR-21 in the brain of AD mice. Additionally, replenishment of miR-21 restored the cognitive deficits in APP/PS1 mice and prevented pathologic features. Taken together, these findings suggest that exosomes from PC-MSCs could improve the learning and memory capabilities of APP/PS1 mice, and that the underlying mechanism may lie in the restoration of synaptic dysfunction and regulation of inflammatory responses through regulation of miR-21.-Cui, G.-H., Wu, J., Mou, F.-F., Xie, W.-H., Wang, F.-B., Wang, Q.-L., Fang, J., Xu, Y.-W., Dong, Y.-R., Liu, J.-R., Guo, H.-D. Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice.
Keywords: Alzheimer disease; inflammatory cytokine; microRNA.
Similar articles
-
Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.BMC Complement Altern Med. 2018 May 29;18(1):167. doi: 10.1186/s12906-018-2237-2. BMC Complement Altern Med. 2018. PMID: 29843688 Free PMC article.
-
RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease.Immun Ageing. 2019 May 13;16:10. doi: 10.1186/s12979-019-0150-2. eCollection 2019. Immun Ageing. 2019. PMID: 31114624 Free PMC article.
-
Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus.Sci Rep. 2020 Jul 1;10(1):10772. doi: 10.1038/s41598-020-67460-1. Sci Rep. 2020. PMID: 32612165 Free PMC article.
-
Mesenchymal Stem Cells-Derived Exosomes: A Possible Therapeutic Strategy for Osteoporosis.Curr Stem Cell Res Ther. 2018;13(5):362-368. doi: 10.2174/1574888X13666180403163456. Curr Stem Cell Res Ther. 2018. PMID: 29623851 Review.
-
[PROGRESS OF MESENCHYMAL STEM CELL-DERIVED Exosomes IN TISSUE REPAIR].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015 Feb;29(2):234-8. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015. PMID: 26455156 Review. Chinese.
Cited by
-
miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury.Stem Cell Res Ther. 2020 Jun 29;11(1):260. doi: 10.1186/s13287-020-01761-0. Stem Cell Res Ther. 2020. PMID: 32600449 Free PMC article.
-
Stem cell therapy for Alzheimer's disease: An overview of experimental models and reality.Animal Model Exp Med. 2022 Feb;5(1):15-26. doi: 10.1002/ame2.12207. Epub 2022 Jan 29. Animal Model Exp Med. 2022. PMID: 35229995 Free PMC article. Review.
-
Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes.Cells. 2019 Apr 3;8(4):307. doi: 10.3390/cells8040307. Cells. 2019. PMID: 30987213 Free PMC article. Review.
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles: An Emerging Diagnostic and Therapeutic Biomolecules for Neurodegenerative Disabilities.Biomolecules. 2023 Aug 16;13(8):1250. doi: 10.3390/biom13081250. Biomolecules. 2023. PMID: 37627315 Free PMC article. Review.
-
Bone-organ axes: bidirectional crosstalk.Mil Med Res. 2024 Jun 12;11(1):37. doi: 10.1186/s40779-024-00540-9. Mil Med Res. 2024. PMID: 38867330 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous